Indrayani Biotech Financials

BSE: 526445

₹8.64

₹0.34 (4.10%)

As on 07-Sep-2026 12:39IST

Market cap

₹65 Cr

Revenue (TTM)

₹173 Cr

P/E Ratio

30

P/B Ratio

0.5

Div. Yield

0 %

Income Statement (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-12	Mar-11	Mar-10	Mar-09
Operating Revenue	172.85	130.23	166.23	162.93	61.57	21.09
Total Income	178.70	133.35	167.44	167.41	61.79	21.35
Total Expenditure	159.58	123.85	142.57	145.62	54.79	26.03
EBITDA	13.27	6.38	23.66	17.31	6.78	-4.94
Depreciation	7.93	3.37	3.80	3.35	0.66	0.46
EBIT	5.35	3.01	19.86	13.96	6.12	-5.40
Interest	10.76	11.88	10.10	5.64	1.89	1.97
Other Income	5.85	3.13	1.21	4.49	0.22	0.27
Exceptional Items	--	--	--	-0.50	--	-4.11
Profit before Tax	0.44	-5.74	10.97	12.31	4.44	-11.21
Provision for Tax	-1.83	0.36	0.55	0.38	--	--
Profit after Tax	2.28	-6.11	10.42	11.93	4.44	-11.21
Minority Interest	-0.56	4.55	-4.06	-3.19	--	0.09
Share of Associate	--	--	--	--	--	--
Consolidated Profit	1.71	-1.56	6.36	8.74	4.44	-11.12

Liabilities (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-12	Mar-11	Mar-10	Mar-09
Shareholder's Funds	72.89	72.51	67.21	55.09	24.16	19.72
Minority Interest	-0.56	27.41	9.05	-6.73	0.41	0.36
Non-Current Liabilities	58.36	65.54	70.33	35.66	7.35	8.17
Current Liabilities	92.98	102.48	87.07	71.91	19.48	11.81
Total Liabilities	253.43	267.94	234.00	155.95	51.40	40.05

Assets (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-12	Mar-11	Mar-10	Mar-09
Non-Current Assets	89.67	90.00	88.69	78.40	32.49	30.90
Current Assets	158.72	177.94	144.98	77.52	18.91	9.15
Total Assets	253.43	267.94	234.00	155.95	51.40	40.05
Total Debt*	--	137.07	107.66	62.75	17.89	15.54
Net Current Assets	65.74	75.45	57.90	5.61	-0.57	-2.65
Contingent Liabilities	--	--	--	--	--	--

Cashflow (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-12	Mar-11	Mar-10	Mar-09
Cash From Operating Activities	--	-6.74	-30.35	16.19	4.11	0.26
Cash Flow from Investing Activities	--	24.74	-16.34	-47.39	-0.56	-0.70
Cash from Financing Activities	--	-18.30	44.24	32.74	-2.73	-0.28
Net Cash Inflow / Outflow	--	-0.29	-2.45	1.53	0.82	-0.72

Financials Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-12	Mar-11	Mar-10	Mar-09
Adjusted EPS (₹)	0.38	-0.37	1.53	2.80	1.42	-3.56
Cash EPS (₹)	0.28	-0.66	3.42	4.89	1.63	-3.44
Adjusted Book Value (₹)	15.59	16.61	15.19	14.18	7.74	6.31
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	--	-1.48	-6.67	4.73	1.20	0.07
Free Cash Flow per Share (₹)	--	-4.82	-12.41	-9.71	0.30	-1.32

Profitability Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-12	Mar-11	Mar-10	Mar-09
ROCE (%)	--	3.19	14.40	22.45	16.38	-23.16
ROE (%)	2.31	-9.25	19.41	34.86	20.23	-112.29
ROA (%)	0.87	-2.44	5.35	11.51	9.71	-24.50
EBIT Margin (%)	3.09	2.31	11.94	8.57	9.94	-25.62
Net Margin (%)	1.27	-4.58	6.22	7.13	7.18	-52.52
Cash Profit Margin (%)	--	-2.10	8.56	9.38	8.28	-51.01

Growth Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-12	Mar-11	Mar-10	Mar-09
Revenue Growth (%)	32.73	-21.66	2.02	164.61	191.97	-57.74
EBIT Growth (%)	263.11	-84.85	42.21	128.08	213.33	-406.54
Net Profit Growth (%)	125.11	-158.60	-12.64	168.74	139.59	-1,489.05
EPS Growth (%)	125.11	-124.45	-45.24	96.79	139.92	-246.65
Book Value Growth (%)	--	9.39	42.45	83.31	22.53	7,675.83

Valuation Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-12	Mar-11	Mar-10	Mar-09
Price / Earnings	30.00	--	35.18	22.14	23.51	--
Price / Book Value	0.53	0.86	3.24	3.98	3.94	1.01
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	13.30	21.23	13.31	12.04	17.25	-7.82
Close Price (₹)	7.92	15.63	53.89	61.94	33.43	6.96
High Price (₹)	22.36	71.96	109.28	126.81	34.42	10.32
Low Price (₹)	6.69	15.43	51.30	30.52	5.21	6.61
Market Cap (₹ Cr)	64.79	64.93	223.91	193.41	104.39	21.73

Solvency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-12	Mar-11	Mar-10	Mar-09
Debt to Equity	0.79	1.99	1.71	1.17	0.74	0.79
Short term debt to equity ratio	--	0.97	0.59	0.58	0.46	0.37
Current Ratio	1.71	1.74	1.67	1.08	0.97	0.78
Quick Ratio	1.30	1.33	1.18	0.91	0.89	0.68
Interest Coverage	1.04	0.52	2.09	3.18	3.35	-4.69

Operating Efficiency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-12	Mar-11	Mar-10	Mar-09
Debtors to sales (%)	33.89	45.07	23.78	18.40	22.90	22.61
Asset Turnover	0.66	0.52	0.85	1.57	1.35	0.46
Receivable days	--	137.64	76.31	49.36	55.92	102.23
Inventory Days	--	117.29	59.91	15.40	7.77	53.33
Payable days	--	134.44	112.97	50.99	40.71	111.00
Cash Conversion Cycle	--	120.49	23.24	13.77	22.98	44.56

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.